Onconetix Sets Nov. 6 Effective Date for 1-for-10 Reverse Stock Split

What happened

Onconetix plans a 1-for-10 reverse stock split effective at 12:01 a.m. ET on November 6, 2026, bringing its total reverse split ratio to 1-for-100. Outstanding shares are expected to fall from about 5.9 million to about 589,000 before fractional-share adjustments.

Confirmed

Global impact / market context

A reverse stock split shrinks the number of shares while raising the price of each one, which means the company's total value does not change by itself. Investors should focus on whether the higher share price helps Onconetix keep its Nasdaq listing.

Analyst inference

The 1-for-100 total ratio suggests Onconetix's share price had fallen sharply, since companies typically use reverse splits to lift a low price. No fractional shares will be issued, and holders will get cash instead, which can create small tax and record-keeping effects for investors.

Analyst inference

What to watch

1. Watch whether the split takes effect at 12:01 a.m. ET on November 6, 2026, and whether ONCO keeps trading on Nasdaq under its existing symbol. Confirmed
2. Watch whether Onconetix later uses its 250 million authorized shares for new stock sales, which would dilute existing holders by spreading ownership across more shares. Proposed
3. Watch the post-split share price for signs of selling pressure, since some holders may exit after the split and the low share count can make the price more volatile. Analyst inference

Evidence

• Original source link unavailable